| Record ID | harvard_bibliographic_metadata/ab.bib.11.20150123.full.mrc:845294197:1232 |
| Source | harvard_bibliographic_metadata |
| Download Link | /show-records/harvard_bibliographic_metadata/ab.bib.11.20150123.full.mrc:845294197:1232?format=raw |
LEADER: 01232pam a2200361 a 4500
001 011955820-3
005 20090603021658.0
008 090428s2007 enka b 001 0 eng
016 7 $a013527860$2Uk
020 $a9781841845258
020 $a1841845256
035 0 $aocm84149745
040 $aUKM$cUKM$dBAKER$dYDXCP
041 0 $aeng
042 $aukscp$anlmcopyc
060 00 $a2007 E-175
060 10 $aWL 360$bM96194 2007
082 04 $a616.83406$222
245 00 $aMultiple sclerosis therapeutics /$ceditors, Jeffrey A. Cohen, Richard A. Rudick.
250 $a3rd ed.
260 $aAbingdon :$bInforma Healthcare ;$aBoca Raton, FL :$bDistributed in North and South America by Taylor & Francis,$c2007.
300 $axxxi, 896 p. :$bill. ;$c26 cm.
500 $aPrevious ed.: London : Martin Dunitz, 2002.
504 $aIncludes bibliographical references and index.
650 22 $aMultiple Sclerosis$xpathology.
650 22 $aMagnetic Resonance Imaging.
650 22 $aClinical Trials as Topic$xmethods.
650 12 $aMultiple Sclerosis$xtherapy.
650 22 $aOutcome Assessment (Health Care)
700 1 $aCohen, Jeffrey A.$q(Jeffrey Alan),$d1954-
700 1 $aRudick, Richard A.
988 $a20090428
906 $0OCLC